Literature DB >> 22134460

Case report on the management of depression in schizoaffective disorder, bipolar type focusing on lithium levels and measurement-based care.

Maju Mathew Koola1, Jan A Fawcett, Deanna L Kelly.   

Abstract

There is little evidence supporting the management of depression in schizoaffective disorder, bipolar type. Managing bipolar depression can be a daunting task for clinicians. Most bipolar patients spend 80% of their time in the depressive phase of illness. In contrast with full-blown mania, patients and family frequently fail to recognize bipolar depression, which may interfere with early diagnosis and treatment. With only a few medications approved for bipolar depression, treatment becomes very challenging. There is evidence to support that schizoaffective depression has a worse outcome than psychotic depression and nonpsychotic depression. We report a patient with schizoaffective disorder, bipolar type with severe depression who responded to an adequate level of lithium and subsequently, on a combination of lithium and quetiapine. Finally, we emphasize the importance of measurement-based care. To our knowledge, this is the first case report focusing on the management of depression in schizoaffective disorder, bipolar type.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134460      PMCID: PMC5441563          DOI: 10.1097/NMD.0b013e3182392d8f

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  6 in total

1.  Is monotherapy as good as polypharmacy in long-term treatment of bipolar disorder?

Authors:  Martin Alda; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2009-11       Impact factor: 4.356

2.  Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.

Authors:  M Tohen; F Zhang; P E Keck; P D Feldman; R C Risser; P V Tran; A Breier
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

Review 3.  The use of antidepressants in bipolar disorder.

Authors:  Virginio Salvi; Andrea Fagiolini; Holly A Swartz; Giuseppe Maina; Ellen Frank
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

4.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

5.  Outcome in schizoaffective, psychotic, and nonpsychotic depression. Course during a six- to 24-month follow-up.

Authors:  W Coryell; P Lavori; J Endicott; M Keller; M VanEerdewegh
Journal:  Arch Gen Psychiatry       Date:  1984-08

6.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Ayal Schaffer; Sagar V Parikh; Serge Beaulieu; Claire O'Donovan; Glenda MacQueen; Roger S McIntyre; Verinder Sharma; Arun Ravindran; L Trevor Young; Allan H Young; Martin Alda; Roumen Milev; Eduard Vieta; Joseph R Calabrese; Michael Berk; Kyooseob Ha; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2009-05       Impact factor: 6.744

  6 in total
  5 in total

1.  A Case of Electroconvulsive Therapy-Resistant Depression Responding to Multiple Dopaminergic Medications.

Authors:  Maju Mathew Koola; Jan A Fawcett
Journal:  Prim Care Companion CNS Disord       Date:  2015-04-30

2.  Opioid use remits, depression remains.

Authors:  Sajoy P Varghese; Maju Mathew Koola; Rodney I Eiger; Maria Devens
Journal:  Curr Psychiatr       Date:  2014-08

3.  Perils of Pragmatic Psychiatry: How We Can Do Better.

Authors:  Maju Mathew Koola; Joseph Sebastian
Journal:  HSOA J Psychiatry Depress Anxiety       Date:  2016-02-23

Review 4.  Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.

Authors:  Maju Mathew Koola; Robert W Buchanan; Anilkumar Pillai; Katherine J Aitchison; Daniel R Weinberger; Scott T Aaronson; Faith B Dickerson
Journal:  Schizophr Res       Date:  2014-05-28       Impact factor: 4.939

Review 5.  High-dose prazosin for the treatment of post-traumatic stress disorder.

Authors:  Maju Mathew Koola; Sajoy P Varghese; Jan A Fawcett
Journal:  Ther Adv Psychopharmacol       Date:  2014-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.